D. Tsiouda

Most-cited papers

1. Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice

   E. Boutsikou, Kalliopi Domvri, G. Hardavella, D. Tsiouda +2 more

   2018Therapeutic Advances in Medical Oncology103 citations Open access

   Semantic Scholar

   Save

2. Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry

   G. Mountzios, D. Planchard, G. Metro, D. Tsiouda +35 more

   2022JTO Clinical and Research Reports18 citations Open access

   Semantic Scholar

   Save

3. 158P Real-world management of patients with EGFR exon 20-mutant NSCLC in the precision oncology era: First report from the European EXOTIC registry

   G. Mountzios, D. Planchard, G. Metro, A. Prelaj +16 more

   2022Annals of Oncology1 citations Open access

   Semantic Scholar

   Save

4. EP08.02-060 How Do Oncologists Treat Patients With EGFR Exon-20 Mutant NSCLC Outside of Clinical Trials? Updated Analysis From the European EXOTIC Registry

   G. Mountzios, D. Planchard, G. Metro, D. Tsiouda +17 more

   2022Journal of Thoracic Oncology0 citations Open access

   Semantic Scholar

   Save

5. Inhaled immunotherapy for lung cancer? Certainly possible

   Pavlos Zarogoulidis, D. Tsiouda, A. Kallianos, A. Rapti +5 more

   2018Lung Cancer0 citations

   Semantic Scholar

   Save